The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Mitochondria-Targeted Chemotherapeutics: The Rational Design of Gold(I) N-Heterocyclic Carbene Complexes That Are Selectively Toxic to Cancer Cells and Target Protein Selenols in Preference to Thiols
Abstract
A family of lipophilic, cationic Au(I) complexes of N-heterocyclic carbenes (NHCs) have been designed as new mitochondria-targeted antitumor agents that combine both selective mitochondrial accumulation and selective thioredoxin reductase inhibition properties within a single molecule. Two-step ligand exchange reactions with cysteine (Cys) and selenocysteine (Sec) occur with release of the NHC ligands. At physiological pH the rate constants for the reactions with Sec are 20- to 80-fold higher than those with Cys. The complexes are selectively toxic to two highly tumorigenic breast cancer cell lines and not to normal breast cells, and the degree of selectivity and potency are optimized by modification of the substituent on the simple imidazolium salt precursor. The lead compound is shown to accumulate in mitochondria of cancer cells, to cause cell death through a mitochondrial apoptotic pathway and to inhibit the activity of thioredoxin reductase (TrxR) but not the closely related and Se-free enzyme glutathione reductase.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
N-Heterocyclic Carbenes: A New Concept in Organometallic Catalysis
Herrmann, W. A. (2002) · Angewandte Chemie International Edition · doi:10.1002/1521-3773(20020415)41:8<1290::aid-anie1290>3.0.co;2-y · Cited by 3,769
Bourissou, D., Guerret, O., Gabbaï, F. P., & Bertrand, G. (2000) · Chemical Reviews · doi:10.1021/cr940472u · Cited by 3,633
The Pathophysiology of Mitochondrial Cell Death
Green, D. R., & Kroemer, G. (2004) · Science · doi:10.1126/science.1099320 · Cited by 3,418
Mitochondrial Membrane Potential in Living Cells
Chen, L. B. (1988) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.04.110188.001103 · Cited by 1,037
Díez-González, S., & Nolan, S. P. (2007) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2006.10.004 · Cited by 939
Ray, S., Mohan, R., Singh, J. K., Samantaray, M. K., Shaikh, M. M., Panda, D., & Ghosh, P. (2007) · Journal of the American Chemical Society · doi:10.1021/ja075889z · Cited by 656
Delocalized lipophilic cations selectively target the mitochondria of carcinoma cells
Modica-Napolitano, J. S., & Aprille, J. R. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00125-9 · Cited by 576
Human Placenta Thioredoxin Reductase
Gromer, S., Arscott, L. D., Williams, C. H., Schirmer, R. H., & Becker, K. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.32.20096 · Cited by 536
N-Heterocyclic carbene–silver complexes: A new class of antibiotics
Kascatan-Nebioglu, A., Panzner, M. J., Tessier, C. A., Cannon, C. L., & Youngs, W. J. (2007) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2006.08.019 · Cited by 479
The thioredoxin system—From science to clinic
Gromer, S., Urig, S., & Becker, K. (2004) · Medicinal Research Reviews · doi:10.1002/med.10051 · Cited by 479
Cited by
An overview of N-heterocyclic carbenes
Hopkinson, M. N., Richter, C., Schedler, M., & Glorius, F. (2014) · Nature · doi:10.1038/nature13384 · Cited by 4,264
N-Heterocyclic Carbenes in Late Transition Metal Catalysis
Díez-González, S., Marion, N., & Nolan, S. P. (2009) · Chemical Reviews · doi:10.1021/cr900074m · Cited by 3,066
Zielonka, J., Joseph, J., Sikora, A., Hardy, M., Ouari, O., Vasquez-Vivar, J., Cheng, G., Lopez, M., & Kalyanaraman, B. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00042 · Cited by 1,683
Organometallic Anticancer Compounds
Gasser, G., Ott, I., & Metzler-Nolte, N. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm100020w · Cited by 1,624
Coinage Metal−N-Heterocyclic Carbene Complexes
Lin, J. C. Y., Huang, R. T. W., Lee, C. S., Bhattacharyya, A., Hwang, W. S., & Lin, I. J. B. (2009) · Chemical Reviews · doi:10.1021/cr8005153 · Cited by 1,036
On the medicinal chemistry of gold complexes as anticancer drugs
Ott, I. (2009) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2009.02.019 · Cited by 825
Metal N-heterocyclic carbene complexes as potential antitumor metallodrugs
Liu, W., & Gust, R. (2013) · Chem. Soc. Rev. · doi:10.1039/c2cs35314h · Cited by 762
Exploration of the medical periodic table: towards new targets
Barry, N. P. E., & Sadler, P. J. (2013) · Chemical Communications · doi:10.1039/c3cc41143e · Cited by 717
Focus on mammalian thioredoxin reductases — Important selenoproteins with versatile functions
Arnér, E. S. J. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2009.01.014 · Cited by 673
Chemical biology of anticancer gold(iii) and gold(i) complexes
Zou, T., Lum, C. T., Lok, C.-N., Zhang, J.-J., & Che, C.-M. (2015) · Chemical Society Reviews · doi:10.1039/c5cs00132c · Cited by 628
N-Heterocyclic carbene metal complexes in medicinal chemistry
Oehninger, L., Rubbiani, R., & Ott, I. (2013) · Dalton Trans. · doi:10.1039/c2dt32617e · Cited by 560
Gold compounds as anticancer agents: chemistry, cellular pharmacology, and preclinical studies
Nobili, S., Mini, E., Landini, I., Gabbiani, C., Casini, A., & Messori, L. (2010) · Medicinal Research Reviews · doi:10.1002/med.20168 · Cited by 503
Bertrand, B., & Casini, A. (2014) · Dalton Trans. · doi:10.1039/c3dt52524d · Cited by 441
Mitochondria-Targeted Small Molecule Therapeutics and Probes
Smith, R. A. J., Hartley, R. C., & Murphy, M. P. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.3969 · Cited by 399
Next-Generation Metal Anticancer Complexes: Multitargeting via Redox Modulation
Romero-Canelón, I., & Sadler, P. J. (2013) · Inorganic Chemistry · doi:10.1021/ic400835n · Cited by 396
Metal-NHC complexes: a survey of anti-cancer properties
Teyssot, M.-L., Jarrousse, A.-S., Manin, M., Chevry, A., Roche, S., Norre, F., Beaudoin, C., Morel, L., Boyer, D., Mahiou, R., et al. (2009) · Dalton Transactions · doi:10.1039/b906308k · Cited by 384
Update on metal N-heterocyclic carbene complexes as potential anti-tumor metallodrugs
Liu, W., & Gust, R. (2016) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2016.09.004 · Cited by 351
Silver coordination compounds: A new horizon in medicine
Medici, S., Peana, M., Crisponi, G., Nurchi, V. M., Lachowicz, J. I., Remelli, M., & Zoroddu, M. A. (2016) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2016.05.015 · Cited by 324
Li, Y., Tan, C.-P., Zhang, W., He, L., Ji, L.-N., & Mao, Z.-W. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2014.10.070 · Cited by 267
Cancer cell death induced by phosphine gold(I) compounds targeting thioredoxin reductase
Gandin, V., Fernandes, A. P., Rigobello, M. P., Dani, B., Sorrentino, F., Tisato, F., Björnstedt, M., Bindoli, A., Sturaro, A., Rella, R., et al. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.07.023 · Cited by 252
Metadata
- Authors
- Hickey, J. L., Ruhayel, R. A., Barnard, P. J., Baker, M. V., Berners-Price, S. J., & Filipovska, A.
- Venue
- Journal of the American Chemical Society
- Publisher
- American Chemical Society (ACS)
- Published
- 2008-08-26
- Volume
- 130
- Issue
- 38
- Pages
- 12570-12571
- ISSN
- 0002-7863 (ISSN-L)
- 1520-5126
- OpenAlex
- W1980437676
- Cited by
- 599
- References
- 25
- FWCI
- 14.78
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.